218 related articles for article (PubMed ID: 37300820)
1. Part 2: mucormycosis: focus on therapy.
Lynch JP; Zhanel GG
Expert Rev Anti Infect Ther; 2023; 21(7):737-748. PubMed ID: 37300820
[TBL] [Abstract][Full Text] [Related]
2. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
3. Mucormycosis.
Reid G; Lynch JP; Fishbein MC; Clark NM
Semin Respir Crit Care Med; 2020 Feb; 41(1):99-114. PubMed ID: 32000287
[TBL] [Abstract][Full Text] [Related]
4. Mucormycosis: The hidden and forgotten disease.
Darwish RM; AlMasri M; Al-Masri MM
J Appl Microbiol; 2022 Jun; 132(6):4042-4057. PubMed ID: 35156271
[TBL] [Abstract][Full Text] [Related]
5. Mucormycosis: New Developments into a Persistently Devastating Infection.
Danion F; Aguilar C; Catherinot E; Alanio A; DeWolf S; Lortholary O; Lanternier F
Semin Respir Crit Care Med; 2015 Oct; 36(5):692-705. PubMed ID: 26398536
[TBL] [Abstract][Full Text] [Related]
6. Treatment of mucormycosis in transplant patients: role of surgery and of old and new antifungal agents.
Chitasombat MN; Kontoyiannis DP
Curr Opin Infect Dis; 2016 Aug; 29(4):340-5. PubMed ID: 27191199
[TBL] [Abstract][Full Text] [Related]
7. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of liposomal amphotericin B and posaconazole in intratracheal models of murine mucormycosis.
Luo G; Gebremariam T; Lee H; French SW; Wiederhold NP; Patterson TF; Filler SG; Ibrahim AS
Antimicrob Agents Chemother; 2013 Jul; 57(7):3340-7. PubMed ID: 23650163
[TBL] [Abstract][Full Text] [Related]
9. Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report.
Cornu M; Bruno B; Loridant S; Navarin P; François N; Lanternier F; Amzallag-Bellenger E; Dubos F; Mazingue F; Sendid B
BMC Pharmacol Toxicol; 2018 Dec; 19(1):81. PubMed ID: 30522521
[TBL] [Abstract][Full Text] [Related]
10. A mucormycosis case in a cirrhotic patient successfully treated with posaconazole and review of published literature.
Lin SY; Lu PL; Tsai KB; Lin CY; Lin WR; Chen TC; Chang YT; Huang CH; Chen CY; Lai CC; Chen YH
Mycopathologia; 2012 Dec; 174(5-6):499-504. PubMed ID: 22744722
[TBL] [Abstract][Full Text] [Related]
11. Current treatments against mucormycosis and future directions.
Smith C; Lee SC
PLoS Pathog; 2022 Oct; 18(10):e1010858. PubMed ID: 36227854
[TBL] [Abstract][Full Text] [Related]
12. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis.
Lynch JP; Fishbein MC; Abtin F; Zhanel GG
Expert Rev Anti Infect Ther; 2023; 21(7):723-736. PubMed ID: 37262298
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the management of mucormycosis: from bench to bedside.
Spellberg B; Walsh TJ; Kontoyiannis DP; Edwards J; Ibrahim AS
Clin Infect Dis; 2009 Jun; 48(12):1743-51. PubMed ID: 19435437
[TBL] [Abstract][Full Text] [Related]
14. Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.
Marty FM; Ostrosky-Zeichner L; Cornely OA; Mullane KM; Perfect JR; Thompson GR; Alangaden GJ; Brown JM; Fredricks DN; Heinz WJ; Herbrecht R; Klimko N; Klyasova G; Maertens JA; Melinkeri SR; Oren I; Pappas PG; Ráčil Z; Rahav G; Santos R; Schwartz S; Vehreschild JJ; Young JH; Chetchotisakd P; Jaruratanasirikul S; Kanj SS; Engelhardt M; Kaufhold A; Ito M; Lee M; Sasse C; Maher RM; Zeiher B; Vehreschild MJGT;
Lancet Infect Dis; 2016 Jul; 16(7):828-837. PubMed ID: 26969258
[TBL] [Abstract][Full Text] [Related]
15. An extensive review on antifungal approaches in the treatment of mucormycosis.
Chaudhari HS; Palkar OS; Abha Mishra KM; Sethi KK
J Biochem Mol Toxicol; 2023 Sep; 37(9):e23417. PubMed ID: 37345721
[TBL] [Abstract][Full Text] [Related]
16. Mucormycosis.
Steinbrink JM; Miceli MH
Infect Dis Clin North Am; 2021 Jun; 35(2):435-452. PubMed ID: 34016285
[TBL] [Abstract][Full Text] [Related]
17. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
[TBL] [Abstract][Full Text] [Related]
18. The cost of treating mucormycosis with isavuconazole compared with standard therapy in the UK.
Bagshaw E; Kuessner D; Posthumus J; Escrig C; Blackney M; Heimann SM; Cornely OA
Future Microbiol; 2017 May; 12():515-525. PubMed ID: 28191796
[TBL] [Abstract][Full Text] [Related]
19. Mucormycosis treated with posaconazole: review of 96 case reports.
Vehreschild JJ; Birtel A; Vehreschild MJ; Liss B; Farowski F; Kochanek M; Sieniawski M; Steinbach A; Wahlers K; Fätkenheuer G; Cornely OA
Crit Rev Microbiol; 2013 Aug; 39(3):310-24. PubMed ID: 22917084
[TBL] [Abstract][Full Text] [Related]
20. Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
Pomorska A; Malecka A; Jaworski R; Radon-Proskura J; Hare RK; Nielsen HV; Andersen LO; Jensen HE; Arendrup MC; Irga-Jaworska N
Mycopathologia; 2019 Feb; 184(1):81-88. PubMed ID: 30039238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
